Few organs cause men as much quiet anxiety as the prostate, a walnut-sized gland whose troubles arrive with age as predictably as grey hair. By 60, most men have some prostate enlargement; by 80, nearly all do. Prostate cancer, meanwhile, is among the commonest cancers in Indian men and is rising with longer lifespans. The confusion between benign enlargement and cancer, and around the PSA blood test that screens for both, leads to both neglect and panic. This guide explains benign prostatic hyperplasia, the warning signs of cancer, and what PSA testing can and cannot tell you.

BPH: the benign enlargement

Benign prostatic hyperplasia is non-cancerous growth of the prostate that squeezes the urethra, producing the classic urinary symptoms: weak stream, hesitancy, dribbling, frequent urination, urgency, getting up multiple times at night (nocturia), and the feeling of incomplete emptying. It is a quality-of-life condition, not a cancer precursor, though the symptoms overlap enough to demand evaluation. Diagnosis involves symptom scoring, physical examination including digital rectal exam, urine tests, ultrasound measuring prostate size and residual urine, and PSA to help exclude cancer. Treatment steps up with severity: lifestyle measures (limiting evening fluids, cutting caffeine and alcohol, timed voiding) for mild cases; alpha-blocker drugs that relax the prostate for moderate symptoms; 5-alpha-reductase inhibitors that shrink the gland over months; and surgical options, from TURP to newer laser procedures, when medicines fail or complications like retention, stones or kidney damage arise.

Prostate cancer: the warning signs

Early prostate cancer usually has no symptoms, which is why screening debates exist. When symptoms appear, they mimic BPH: urinary difficulty, blood in urine or semen, erectile difficulty, and in advanced disease, bone pain (especially back and hips), weight loss and fatigue. Risk rises with age, family history (father or brother with prostate cancer), and possibly high-fat diets and obesity; African ancestry carries higher risk globally. Indian incidence is lower than Western but climbing, and Indian patients often present later, at more advanced stages. Any persistent urinary change in a man over 50, blood in urine or semen, or unexplained bone pain deserves prompt urological evaluation, not months of waiting.

The PSA test: what it reveals and its limits

Prostate-specific antigen is a protein made by prostate cells; blood levels rise with enlargement, inflammation, infection and cancer alike. That non-specificity is the test’s blessing and curse. PSA screening catches cancers early and has reduced prostate cancer deaths where used systematically, but it also detects slow-growing cancers that would never have harmed the patient, leading to overdiagnosis and overtreatment with life-altering side effects like incontinence and impotence. PSA can also be raised by recent ejaculation, cycling, urinary infection or prostate examination, and some aggressive cancers produce little PSA. Modern practice refines the test: PSA density, free-to-total PSA ratio, MRI before biopsy, and risk calculators reduce unnecessary biopsies. In India, guidelines generally suggest informed, individualised PSA screening from 50, earlier with family history, as a discussion, not an automatic order.

What happens after a high PSA?

A raised PSA triggers evaluation, not panic. The urologist repeats the test, treats any infection, examines the prostate and increasingly orders a multiparametric MRI, which maps suspicious areas precisely. If concern persists, a targeted biopsy, guided by MRI and ultrasound, samples the prostate; this is a day-care procedure with antibiotic cover. If cancer is found, grading (Gleason score) and staging determine management: active surveillance for low-risk disease, surgery or radiation for localised significant cancer, and hormonal therapy with other systemic treatments for advanced disease. Active surveillance, monitoring low-risk cancer without immediate treatment, is a major advance that spares many men unnecessary therapy.

Protecting prostate health

No lifestyle guarantees a healthy prostate, but the usual suspects help: healthy weight, regular exercise, a diet rich in vegetables and tomatoes (lycopene), limited red meat and high-fat dairy, and not smoking. Ejaculation frequency has been weakly linked to lower risk in some studies, though the evidence is modest. What matters most is engagement: men must overcome the reluctance to discuss urinary symptoms or undergo rectal examination, a cultural barrier that delays Indian diagnoses. Annual health checks after 50 that include a prostate conversation catch problems at treatable stages.

FAQs

Does BPH turn into cancer? No. They are separate conditions that happen to share an organ and an age group; BPH does not become malignant.

Can PSA be normal in prostate cancer? Yes, occasionally, which is why symptoms and examination still matter alongside the blood test.

Is prostate surgery the only option for BPH? No. Most men are managed with medicines; surgery is reserved for inadequate response or complications, and minimally invasive options keep expanding.

The prostate demands neither panic nor neglect but proportionate attention. Know the urinary warning signs, discuss PSA screening intelligently with your doctor after 50, and treat BPH symptoms early for quality of life. In prostate health, as elsewhere, the examined life wins.

Compiled by the Khabar 24h Editorial Desk from publicly available sources.